Long-term effects of dupilumab on chronic rhinosinusitis with nasal polyps: A step towards clinical remission
Background and objectives: Clinical remission, defined as the absence of disease activity and symptoms, is an emerging goal in the management of chronic rhinosinusitis with nasal polyps (CRSwNP). This study aimed to evaluate the long-term effects of dupilumab on patients with CRSwNP, with or without...
Saved in:
Main Authors: | Mona Al-Ahmad, MD, FRCPC, Asmaa Ali, MD, PhD, Wafaa Talat, MD, PhD, Haitham A. Dawood, MD, PhD, Osama Imam, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | World Allergy Organization Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193945512400156X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, MD, et al.
Published: (2025-05-01) -
Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps
by: Shaun J. Kilty, et al.
Published: (2022-04-01) -
The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP
by: Nicholas J. Campion, et al.
Published: (2023-09-01) -
Remission: does it already exist in chronic rhinosinusitis with nasal polyposis?
by: Yvonne Chan, et al.
Published: (2023-07-01) -
Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach
by: Oliver Pfaar, et al.
Published: (2025-01-01)